Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti‐oncostatin M antibody inhibits the pro‐malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma
Justyna Kucia-Tran, Valtteri Tulkki, Cinzia G. Scarpini, et al.
The Journal of Pathology (2017) Vol. 244, Iss. 3, pp. 283-295
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
María Florencia Soler, Andrea Abaurrea, Peio Azcoaga, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007530-e007530
Open Access | Times Cited: 62
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Angela M. Araujo, Andrea Abaurrea, Peio Azcoaga, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 40
Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems
Natalie A. Sims, Jean-Pierre Lévesque
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 80-95
Open Access | Times Cited: 9
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer
Deepak Parashar, Anjali Geethadevi, Miriam R. R. Aure, et al.
Cell Reports (2019) Vol. 29, Iss. 13, pp. 4389-4406.e10
Open Access | Times Cited: 74
Oncostatin M: A mysterious cytokine in cancers
Ali Masjedi, Farnaz Hajizadeh, Farzaneh Beigi Dargani, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107158-107158
Closed Access | Times Cited: 66
Oncostatin M Reduces Pathological Neovascularization in the Retina Through Müller Cell Activation
Julian Rapp, Alban Hospach, Paula Liang, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 1, pp. 22-22
Open Access | Times Cited: 5
OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung
Ken Tawara, Celeste Bolin, Jordan Koncinsky, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Annexin A2–STAT3–Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma
Yuji Matsumoto, Tomotsugu Ichikawa, Kazuhiko Kurozumi, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 24
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer
Alessandra Caligiuri, Stefano Gitto, Giulia Lori, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4211-4211
Open Access | Times Cited: 13
OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition
Francesca Lantieri, Tiziana Bachetti
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11096-11096
Open Access | Times Cited: 13
Balancing STAT Activity as a Therapeutic Strategy
Kelsey L. Polak, Noah M. Chernosky, Jacob Smigiel, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1716-1716
Open Access | Times Cited: 22
Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal Programs
Kelsey L. Polak, Ilaria Tamagno, Neetha Parameswaran, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 975-990
Open Access | Times Cited: 6
Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3)
Simona Sterbova, Terese Karlsson, Emma Persson
Biochemical and Biophysical Research Communications (2018) Vol. 498, Iss. 4, pp. 769-774
Closed Access | Times Cited: 14
Role of Oncostatin M in Exercise-Induced Breast Cancer Prevention
Kara A. Negrini, Dan Lin, Dhruvil Shah, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2716-2716
Open Access | Times Cited: 1
Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis
Umesh Kathad, Neha Biyani, Raniero L. Peru y Colón De Portugal, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308604-e0308604
Open Access | Times Cited: 1
lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma
Zhaoyun Liu, Mei Han, Nanhao Meng, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 10
Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery
Olga A. Mass, Joseph P. Tuccinardi, Luke Woodbury, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Oncostatin M, Serpins, and Oxidative Stress in Extracellular Matrix Remodeling and Arteriovenous Fistula Maturation
Nathaniel DeMarco, Vikrant Rai, Daniel Wilson, et al.
Cardiology and Cardiovascular Medicine (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 3
Breaking the oncostatin M feed‐forward loop to suppress metastasis and therapy failure
Jacob Smigiel, Jenny G. Parvani, Ilaria Tamagno, et al.
The Journal of Pathology (2018) Vol. 245, Iss. 1, pp. 6-8
Open Access | Times Cited: 7
Activation of OSM-STAT3 Epigenetically Regulates Tumor-Promoting Transcriptional Programs in Cervical Cancer
Junho Noh, Chaelin You, Keunsoo Kang, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6090-6090
Open Access | Times Cited: 4
Integrative transcriptomic analysis for linking acute stress responses to squamous cell carcinoma development
Tran Nguyen, Kimal Rajapakshe, Courtney Nicholas, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling
Carolyn D. Hurst, Guo Cheng, Fiona M. Platt, et al.
The Journal of Pathology Clinical Research (2022) Vol. 8, Iss. 3, pp. 279-293
Open Access | Times Cited: 3
Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program
Noah M. Chernosky, Ilaria Tamagno, Kelsey L. Polak, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access
Oncostatin M receptor is overexpressed in oral squamous cell carcinoma and connected to poor prognosis
Qifeng Geng, Jing Wang, Wei Zhang, et al.
Journal of Oral Pathology and Medicine (2022) Vol. 52, Iss. 2, pp. 136-144
Closed Access | Times Cited: 1
Cytokine Receptors
Alison McFarlane, Paul K. Fyfe, Ignacio Moraga
Elsevier eBooks (2021), pp. 37-64
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top